Persistent Post Concussion Syndrome

2

Review clinical trials related to Persistent Post Concussion Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).

Participants needed: 30
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: University of MinnesotaUpdated: Mar 17, 2026Locations: 1
Eligibility criteria

Age 18-65 [+3]

Inability to provide informed consent or complete study procedures [+4]

Status: Recruiting

Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms

Many combat veterans (c-Vs), service members (SMs) and civilians with mild traumatic brain injury (mTBI, also termed concussion) suffer from persistent post-concussion symptoms (PPCS) that degrade physical and cognitive well-being and have been linked with early neurodegeneration. PPCS include somatosensory (e.g., headache, disturbed vision), vestibular (e.g., dizzy, clumsy), cognitive (e.g., executive function, memory) and affective symptoms (e.g., sleep disturbance, irritability, depression). A key pathological process that provokes and perpetuates PPCS is autonomic nervous system (ANS) dysfunction such as unremitting sympathetic nervous system activation that also exacerbates other pathology such as inflammation. ANS activity can be readily quantified by measuring heart rate variability (HRV), or the variation in heart rate over time, which serves as a valid index of both physiological and psychological health

Participants needed: 148
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Virginia Commonwealth UniversityUpdated: Sep 17, 2025Locations: 1
Eligibility criteria

age 18 or older [+7]

Any TBI with severity greater than mild (i.e., Moderate or Severe TBI defined as... [+3]